Search
-
CompanyAtlas Molecular Pharma
-
CompanyALLBIOTECH S.L.
-
NewYsios Capital launches InceptionBio, a €100M fund to drive biotech company creation
InceptionBio is a new €100 million target-size fund focused on biotech company creation and early-stage projects, with a strong focus on Spain.
-
NewJosep Samitier: "It's key to strengthen public private collaboration and attract venture ...
Josep Samitier, a leading figure in bioengineering and nanomedicine, reflects on the key milestones of his time at the helm of IBEC and discusses the challenges facing the biotech ecosystem in Spain
-
NewORYZON strengthens vafidemstat patent portfolio with U.S. Notice of Allowance
Covers the use of vafidemstat for treating non-aggressive symptoms of Borderline Personality Disorder (BPD).
-
NewAptadel Therapeutics raises 2 million euros and prepares a new round to bring the projec...
Aptadel Therapeutics advances in its treatment for Ewing's sarcoma after closing a bridge round of 2 million euros.
-
NewMTBVAC moves toward its final stage: the vaccine candidate that could mark a turning point...
According to WHO and ECDC data, 161,569 cases were reported in 2024 across 51 of the 53 countries in the European region, equivalent to 17.2 cases per 100,000 inhabitants.
-
Press releaseMTBVAC moves toward its final stage: the vaccine candidate that could mark a turning point...
According to WHO and ECDC data, 161,569 cases were reported in 2024 across 51 of the 53 countries in the European region, equivalent to 17.2 cases per 100,000 inhabitants. One of the main challenges
-
NewORYZON announces U.S. patent grant covering iadademstat combinations with venetoclax
Recent data from an ongoing study in first-line AML showed a 100% overall response rate (ORR) with iadademstat in combination with venetoclax and azacitidine.
-
NewGSK opens Spain’s first maximum biosecurity laboratory
Spain Prime Minister, Pedro Sánchez, recently visited the first maximum biosafety level (BSL-4) laboratory in Spain, located in Tres Cantos (Madrid). It is the world's only facility of its kind
-
NewAseBio promotes in Brussels the vision of the Spanish biotechnology sector on the Biotech ...
Our Director General, Ion Arocena, participated in the latest meeting of the MEP Interest Group “EU Biotech and Life Sciences Alliance” with the aim of bringing clarity and guidance to the European
-
-
NewYsios Capital appoints Joan Perelló as Managing Partner and Arturo Urrios as Partner to d...
Joan Perelló and Arturo Urrios will lead a new vertical focused on company creation and early-stage biotech projects, with a strong focus on Spain.
-
New#NewAseBioMember | "AseBio is the main meeting point for the biotechnology sector in Spain...
Meet Arquea Biological Innovations, our new member. We spoke with Fernando Garcia Osorio, CEO.
-
New#NewAseBioMember | “AseBio represents credibility, sector cohesion, and a unified voice”
Meet Macami Biotech, our new member. We spoke with Miguel Rodríguez-Villa Förster, CEO.
-
NewPromising results for GAT Therapeutics drug in development for pulmonary fibrosis
The biotech company GAT Therapeutics, based at the University of Barcelona Parc Científic de Barcelona (PCB-UB), is making progress in the development of GTX-11, a new oral drug candidate for the
-
CompanyTEKNIKER
-
NewGENESIS Biomed sponsors the 4th Conference on Healthcare Entrepreneurship at the Gregorio ...
The conference was organised by the UAI (Innovation Support Unit) of the IiSGM (Gregorio Marañón Health Research Institute) and was sponsored by GENESIS Biomed, HOFFMANN EITLE, DINAMIZA Health
-
-
NewORYZON expands patent protection for iadademstat with grant decision in Mexico covering co...
Key combination for the treatment of Small Cell Lung Cancer.
-
EventON HELIX 2026